Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antonio Bayés de Luna is active.

Publication


Featured researches published by Antonio Bayés de Luna.


American Heart Journal | 1989

Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

Antonio Bayés de Luna; Philippe Coumel; Jean François Leclercq

The study of the tapes of ambulatory patients who died while wearing Holter devices allows us to know the terminal electrical events of death in these cases and which are the electrical triggering mechanisms leading to the terminal event. From the evaluation of seven published series with 10 or more cases, we can see that the most frequent causes of sudden death are ventricular tachyarrhythmias (84% of cases) and bradyarrhythmias (16%). VF was the most frequent ventricular tachyarrhythmia, usually secondary to VT. The rest were due to torsades de pointes in patients often without heart disease but who were taking antiarrhythmic drugs. The VT leading to VF was often preceded by sinus tachycardia or new atrial tachyarrhythmia. Only a small percentage of patients presented ischemic ST changes. In patients who died due to bradyarrhythmias, this was more often due to sinus depression than to atrioventricular block.


Circulation | 2004

Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases

Barry J. Maron; Bernard R. Chaitman; Michael J. Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E. Crosson; Barbara J. Deal; David J. Driscoll; N.A. Mark Estes; Claudio Gil Soares de Araújo; David Liang; Matthew J. Mitten; Robert J. Myerburg; Antonio Pelliccia; Paul D. Thompson; Jeffrey A. Towbin; Steven P. Van Camp

A group of relatively uncommon but important genetic cardiovascular diseases (GCVDs) are associated with increased risk for sudden cardiac death during exercise, including hypertrophic cardiomyopathy, long-QT syndrome, Marfan syndrome, and arrhythmogenic right ventricular cardiomyopathy. These conditions, characterized by diverse phenotypic expression and genetic substrates, account for a substantial proportion of unexpected and usually arrhythmia-based fatal events during adolescence and young adulthood. Guidelines are in place governing eligibility and disqualification criteria for competitive athletes with these GCVDs (eg, Bethesda Conference No. 26 and its update as Bethesda Conference No. 36 in 2005). However, similar systematic recommendations for the much larger population of patients with GCVD who are not trained athletes, but nevertheless wish to participate in any of a variety of recreational physical activities and sports, have not been available. The practicing clinician is frequently confronted with the dilemma of designing noncompetitive exercise programs for athletes with GCVD after disqualification from competition, as well as for those patients with such conditions who do not aspire to organized sports. Indeed, many asymptomatic (or mildly symptomatic) patients with GCVD desire a physically active lifestyle with participation in recreational and leisure-time activities to take advantage of the many documented benefits of exercise. However, to date, no reference document has been available for ascertaining which types of physical activity could be regarded as either prudent or inadvisable in these subgroups of patients. Therefore, given this clear and present need, this American Heart Association consensus document was constituted, based largely on the experience and insights of the expert panel, to offer recommendations governing recreational exercise for patients with known GCVDs.


Journal of Electrocardiology | 2012

Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report ☆

Antonio Bayés de Luna; Josep Brugada; Adrian Baranchuk; Martin Borggrefe; Guenter Breithardt; Diego Goldwasser; Pier D. Lambiase; Andres Ricardo Perez Riera; Javier García-Niebla; Carlos Alberto Pastore; Giuseppe Oreto; William J. McKenna; Wojciech Zareba; Ramon Brugada; Pedro Brugada

Brugada syndrome is an inherited heart disease without structural abnormalities that is thought to arise as a result of accelerated inactivation of Na channels and predominance of transient outward K current (I(to)) to generate a voltage gradient in the right ventricular layers. This gradient triggers ventricular tachycardia/ventricular fibrillation possibly through a phase 2 reentrant mechanism. The Brugada electrocardiographic (ECG) pattern, which can be dynamic and is sometimes concealed, being only recorded in upper precordial leads, is the hallmark of Brugada syndrome. Because of limitations of previous consensus documents describing the Brugada ECG pattern, especially in relation to the differences between types 2 and 3, a new consensus report to establish a set of new ECG criteria with higher accuracy has been considered necessary. In the new ECG criteria, only 2 ECG patterns are considered: pattern 1 identical to classic type 1 of other consensus (coved pattern) and pattern 2 that joins patterns 2 and 3 of previous consensus (saddle-back pattern). This consensus document describes the most important characteristics of 2 patterns and also the key points of differential diagnosis with different conditions that lead to Brugada-like pattern in the right precordial leads, especially right bundle-branch block, athletes, pectus excavatum, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Also discussed is the concept of Brugada phenocopies that are ECG patterns characteristic of Brugada pattern that may appear and disappear in relation with multiple causes but are not related with Brugada syndrome.


Journal of Electrocardiology | 2012

Interatrial blocks. A separate entity from left atrial enlargement: a consensus report

Antonio Bayés de Luna; Pyotr G. Platonov; Francisco G. Cosio; Iwona Cygankiewicz; Carlos Alberto Pastore; Rafa Baranowski; Antoni Bayes-Genis; Josep Guindo; Xavier Viñolas; Javier García-Niebla; Raimundo Barbosa; Shlomo Stern; David H. Spodick

Impaired interatrial conduction or interatrial block is well documented but is not described as an individual electrocardiographic (ECG) pattern in most of ECG books, although the term atrial abnormalities to encompass both concepts, left atrial enlargement (LAE) and interatrial block, has been coined. In fact, LAE and interatrial block are often associated, similarly to what happens with ventricular enlargement and ventricular block. The interatrial blocks, that is, the presence of delay of conduction between the right and left atria, are the most frequent atrial blocks. These may be of first degree (P-wave duration >120 milliseconds), third degree (longer P wave with biphasic [±] morphology in inferior leads), and second degree when these patterns appear transiently in the same ECG recording (atrial aberrancy). There are evidences that these electrocardiographic P-wave patterns are due to a block because they may (a) appear transiently, (b) be without associated atrial enlargement, and (c) may be reproduced experimentally. The presence of interatrial blocks may be seen in the absence of atrial enlargement but often are present in case of LAE. The most important clinical implications of interatrial block are the following: (a) the first degree interatrial blocks are very common, and their relation with atrial fibrillation and an increased risk for global and cardiovascular mortality has been demonstrated; (b) the third degree interatrial blocks are less frequent but are strong markers of LAE and paroxysmal supraventricular tachyarrhythmias. Their presence has been considered a true arrhythmological syndrome.


American Journal of Cardiology | 1997

Comparison of Morphologic Assessment of Hypertrophic Cardiomyopathy by Magnetic Resonance Versus Echocardiographic Imaging

Guillem Pons-Lladó; Francesc Carreras; Xavier Borrás; Jaume Palmer; Jaume Llauger; Antonio Bayés de Luna

To compare the value of echocardiography and magnetic resonance imaging (MRI) in the assessment of the amount and extent of hypertrophy in hypertrophic cardiomyopathy (HC) and, second, to correlate the degree of hypertrophy, as assessed by MRI, with clinical and electrocardiographic parameters, 30 consecutive patients (16 men and 14 women, aged 20 to 74 years) with HC were studied. Measurements of left ventricular wall thickness were performed at 11 predetermined segments (5 basal, 5 midventricular, and 1 apical) by 2-dimensional echocardiography and MRI. Two parameters derived from MRI studies were considered as indicators of the degree and extent of hypertrophy: (1) mean of the measured wall thickness at the 11 segments, and (2) the number of segments with thickness > 15 mm. Results showed that, from a total of 330 myocardial segments, thickness could be measured by echocardiography in 221 (67%), whereas MRI allowed measurement of 320 segments (97%). When compared with clinical and electrocardiographic data, no correlation was found regarding mean wall thickness and number of hypertrophied segments by MRI except for the presence of an abnormal electrocardiographic repolarization pattern. It is concluded that MRI allows a better assessment of the degree and extension of left ventricular hypertrophy than echocardiography in HC. Despite the precise information on hypertrophy provided by MRI, the amount and degree of hypertrophy bears no correlation with most of the clinical data in these patients.


American Journal of Cardiology | 1993

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction

Francisco Navarro-Lopez; Juan Cosin; Jaume Marrugat; Juan Guindo; Antonio Bayés de Luna

A randomized trial was conducted to assess the efficacy of amiodarone versus metoprolol or no antiarrhythmic treatment to suppress asymptomatic ectopic activity and improve survival in patients who have had myocardial infarction with a left ventricular ejection fraction of 20 to 45% and > or = 3 ventricular premature complexes per hour (pairs or runs). Patients (n = 368) were randomly assigned to receive amiodarone 200 mg/day (n = 115) 10 to 60 days after the acute episode, and metoprolol 100 to 200 mg/day (n = 130) or no antiarrhythmic therapy (n = 123). After a median follow-up of 2.8 years, mortality in the amiodarone-treated patients (3.5 +/- 2% SEM) did not differ significantly from that of untreated control subjects (7.7 +/- 2.5%, p = 0.19), but was lower than that in the metoprolol group (15.4 +/- 3.5%, p = 0.006). Patients treated with metoprolol had twice the mortality seen in control subjects, even though the differences were not statistically significant. Holter studies performed at 1, 6 and 12 months showed that both amiodarone and metoprolol were equally effective in reducing heart rate, whereas only amiodarone significantly reduced ectopic activity (p < 0.0001). Thus, long-term treatment with amiodarone was clearly safe in patients with an ejection fraction of 20 to 45%, was effective in suppressing arrhythmias, and was associated with a lower mortality than metoprolol; corroboration is required in a larger trial.


Annals of Noninvasive Electrocardiology | 2008

Reproducibility and Gender-Related Differences of Heart Rate Variability during All-Day Activity in Young Men and Women

Juan Sztajzel; Michel Jung; Antonio Bayés de Luna

Background: Only few data are available on reproducibility over time in healthy young men and women and the corresponding gender‐related changes of heart rate variability (HRV) measurements.


Annals of Noninvasive Electrocardiology | 2009

Technical Mistakes during the Acquisition of the Electrocardiogram

R N Javier García-Niebla; Pablo Llontop-García; R N Juan Ignacio Valle-Racero; Guillem Serra-Autonell; Velislav N. Batchvarov; Antonio Bayés de Luna

In addition to knowledge of normal and pathological patterns, the correct interpretation of electrocardiographic (ECG) recordings requires the use of acquisition procedures according to approved standards. Most manuals on standard electrocardiography devote little attention to inadequate ECG recordings. In this article, we present the most frequent ECG patterns resulting from errors in limb and precordial lead placement, artifacts in 12‐lead ECG as well as inadequate filter application; we also review alternative systems to the standard ECG, which may help minimize errors.


Journal of Electrocardiology | 2012

Common pitfalls in the interpretation of electrocardiograms from patients with acute coronary syndromes with narrow QRS: a consensus report

Yochai Birnbaum; Antonio Bayés de Luna; Miquel Fiol; Kjell Nikus; Peter W. Macfarlane; Anton P.M. Gorgels; Alessandro Sionis; Juan Cinca; José A. Barrabés; Olle Pahlm; Samuel Sclarovsky; Hein J. J. Wellens; Leonard S. Gettes

Acute coronary syndromes (ACS) with narrow QRS are divided into 2 groups: ST-elevation ACS that requires emergency percutaneous coronary intervention, and non-ST elevation ACS. The classification of ACS into these 2 groups is not always straightforward. In this document, we discuss several electrocardiogram patterns of acute ischemia that are often misinterpreted. We suggest that any new recommendations or guidelines from the Scientific Societies should acknowledge these aspects of electrocardiogram interpretation by including appropriate diagnostic criteria that should prove helpful for the optimal management of patients with ACS.


International Journal of Cardiology | 1989

Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.

Antonio Bayés de Luna; M.Cladellas R. Oter; Josep Guindo

Patients with advanced interatrial conduction block with retrograde activation to the left atrium present a high incidence of supraventricular tachyarrhythmias. We report the value of preventive antiarrhythmic treatment in these patients.

Collaboration


Dive into the Antonio Bayés de Luna's collaboration.

Top Co-Authors

Avatar

Javier García-Niebla

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Iwona Cygankiewicz

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pere Caminal

Polytechnic University of Catalonia

View shared research outputs
Top Co-Authors

Avatar

Miquel Fiol

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Manuel Martínez-Sellés

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Montserrat Vallverdú

Polytechnic University of Catalonia

View shared research outputs
Top Co-Authors

Avatar

Wojciech Zareba

University of Rochester Medical Center

View shared research outputs
Top Co-Authors

Avatar

Josep Guindo

Autonomous University of Barcelona

View shared research outputs
Researchain Logo
Decentralizing Knowledge